GEVO Gevo, Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 1392380 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY80.1%
TTM net income YoY-303.6%
TTM EPS YoY-261.9%
Revenue 3-yr CAGR153.5%
Net income 3-yr CAGR—
Margins
Gross margin51.2%
Operating margin-68.2%
Net margin-83.7%
FCF margin-14.2%
EBITDA margin-56.5%
Returns
ROE-47.5%
ROA-29.7%
ROIC (approx.)-24.5%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets42.9%
Debt / equity0.56x
Current ratio2.04x
Interest coverage-7.05x
Cash quality & payout
Operating cash flow / net income-0.18x
Accruals ratio-35.0%
Payout ratio—
Capex / revenue28.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $82.95M | $46.50M | $42.95M | $45.35M | $42.71M | $43.41M | $29.11M | $5.70M |
| Cost of revenue | $28.22M | $19.92M | $20.23M | $24.25M | $22.29M | $17.27M | $21.45M | $3.45M |
| Gross profit | $47.81M | $19.80M | $22.72M | $21.10M | $13.02M | $18.93M | $7.66M | $2.25M |
| R&D expense | $1.14M | $440,000 | $1.50M | $1.29M | $1.27M | $934,000 | $1.05M | $1.27M |
| SG&A expense | $13.71M | $12.88M | $16.21M | $17.69M | $11.65M | $10.78M | $11.08M | $10.46M |
| Operating income | $30.20M | -$171.71M | -$4.90M | -$2.18M | -$3.69M | $5.80M | -$20.14M | -$19.65M |
| Interest expense | $5.55M | $5.63M | $5.17M | $4.71M | $5.21M | $4.34M | $3.29M | $1.12M |
| Income tax | $0 | $0 | $0 | — | $0 | $0 | $0 | — |
| Net income | $22.71M | -$176.94M | -$21.70M | -$6.30M | -$7.95M | $2.14M | -$21.73M | -$17.61M |
| EBITDA | $37.12M | -$164.92M | $1.96M | $2.90M | $3.71M | $13.01M | -$14.52M | -$13.57M |
| EPS (basic) | 0.10 | -0.75 | -0.09 | — | -0.03 | 0.01 | -0.09 | — |
| EPS (diluted) | 0.09 | -0.75 | -0.09 | — | -0.03 | 0.01 | -0.09 | — |
| Weighted avg. shares (diluted) | 240.89M | 237.05M | 236.84M | — | 232.68M | 236.84M | 232.03M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $67.55M | $58.15M | $78.90M | $81.16M | $72.60M | $57.26M | $65.29M | $259.03M |
| Receivables | $27.34M | $11.97M | $9.74M | $8.39M | $7.74M | $11.03M | $11.75M | $2.41M |
| Inventory | $20.18M | $19.30M | $21.59M | $19.08M | $21.91M | $16.94M | $16.79M | $4.50M |
| Current assets | $119.97M | $101.60M | $115.87M | $143.40M | $136.71M | $170.44M | $103.86M | $203.71M |
| PP&E, net | $256.35M | $238.12M | $358.17M | $353.58M | $343.34M | $344.91M | $339.07M | $221.64M |
| Goodwill | $43.56M | $43.56M | $43.56M | $43.56M | $43.56M | $43.56M | $43.56M | $3.74M |
| Intangibles | $86.09M | $71.59M | $60.08M | $95.00M | $79.56M | $70.33M | $52.11M | $8.13M |
| Total assets | $540.24M | $490.71M | $653.50M | $718.93M | $685.21M | $718.93M | $718.93M | $583.94M |
| Current liabilities | $58.80M | $37.64M | $26.89M | $78.58M | $71.66M | $73.23M | $51.00M | $24.36M |
| Short-term debt | $0 | $0 | — | $0 | $30.28M | $27.89M | $19.93M | $21,000 |
| Long-term debt | $167.77M | $167.24M | $166.75M | $164.75M | $134.19M | $139.60M | $147.09M | $67.11M |
| Total debt | $167.77M | $167.24M | $166.75M | $164.75M | $164.47M | $167.49M | $167.01M | $67.13M |
| Total liabilities | $231.70M | $209.76M | $198.80M | $247.76M | $210.38M | $222.35M | $203.01M | $94.45M |
| Shareholders' equity | $298.40M | $273.16M | $447.75M | $466.34M | $468.87M | $474.10M | $469.84M | $489.49M |
| Net debt | $100.22M | $109.09M | $87.85M | $83.59M | $91.87M | $110.23M | $101.73M | -$191.90M |
| Shares outstanding | 247.38M | 247.24M | 243.07M | 242.46M | 242.12M | 241.84M | 239.56M | 239.18M |
| Cash flow statement | ||||||||
| Operating cash flow | $41.44M | -$8.28M | -$21.14M | $19.95M | -$6.79M | -$2.52M | -$24.05M | -$18.84M |
| Capital expenditure | $30.22M | $12.49M | $8.88M | $11.21M | $7.83M | $5.24M | $5.83M | $14.63M |
| Free cash flow | $11.22M | -$20.77M | -$30.02M | $8.75M | -$14.62M | -$7.76M | -$29.88M | -$33.47M |
| Investing cash flow | -$32.11M | -$12.49M | -$9.12M | -$9.21M | -$7.83M | -$5.24M | -$204.29M | -$14.63M |
| Financing cash flow | $73,000 | $14,000 | -$7.77M | -$2.18M | -$3.91M | -$266,000 | $104.24M | -$369,000 |
| Depreciation & amortization | $6.92M | $6.78M | $6.86M | $5.08M | $7.40M | $7.21M | $5.62M | $6.08M |
| Stock-based compensation | $2.44M | $2.56M | $2.10M | $2.71M | $2.36M | $2.24M | $1.90M | $2.25M |
| Share buybacks | $9,000 | — | — | — | $0 | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.